Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Other financing activities (2021 - 2025)

Biomea Fusion (BMEA) posted Other financing activities of -$594000.0 for Q4 2025, down 193.4% sequentially from $636000.0 in Q3 2025, and down 135.61% YoY from $1.7 million in Q4 2024.

Biomea Fusion (BMEA) Other financing activities (2021 - 2025) Analysis & Trends

Biomea Fusion has reported Other financing activities for 5 years, with the latest figure at -$594000.0 in Q4 2025.

  • Quarterly Other financing activities fell 135.61% year-over-year to -$594000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $159000.0 (down 90.47% YoY) and the FY2025 annual result came in at $159000.0, down 90.47% from the prior year.
  • Other financing activities declined to -$594000.0 in Q4 2025 per BMEA's latest filing, from $636000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $152.5 million in Q3 2021 and troughed at -$152.3 million in Q4 2021.
  • A 5-year average of $353600.0 and a median of $318000.0 in 2022 frame the typical range for Other financing activities.
  • The sharpest annual moves came in 2023 and 2025: Other financing activities surged 548.39% in 2023, then slumped 135.61% in 2025.
  • Over 5 years, Other financing activities stood at -$152.3 million in 2021, then jumped by 100.32% to $490000.0 in 2022, then rose by 26.94% to $622000.0 in 2023, then jumped by 168.17% to $1.7 million in 2024, then plunged by 135.61% to -$594000.0 in 2025.
  • According to Business Quant data, Other financing activities over the past three periods registered -$594000.0, $636000.0, and $112000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Biomea Fusion 97.69 Mn 97.69 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -594,000.00
Dec 31, 2025 -594,000.00
Sep 30, 2025 636,000.00
Sep 30, 2025 636,000.00
Jun 30, 2025 112,000.00
Jun 30, 2025 112,000.00
Mar 31, 2025 5,000.00
Mar 31, 2025 5,000.00
Dec 31, 2024 1.67 Mn
Dec 31, 2024 1.67 Mn
Dec 31, 2023 622,000.00
Dec 31, 2023 622,000.00
Sep 30, 2023 138,000.00
Sep 30, 2023 138,000.00
Jun 30, 2023 1.03 Mn
Jun 30, 2023 1.03 Mn
Mar 31, 2023 201,000.00
Mar 31, 2023 201,000.00
Dec 31, 2022 490,000.00
Dec 31, 2022 490,000.00